Brawn Biotech Limited (BOM:530207)
22.00
+0.57 (2.66%)
At close: Jan 22, 2026
Brawn Biotech Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Cash & Equivalents | 1.89 | 1.99 | 3.97 | 4.39 | 2.25 | 3.96 | Upgrade |
Cash & Short-Term Investments | 1.89 | 1.99 | 3.97 | 4.39 | 2.25 | 3.96 | Upgrade |
Cash Growth | -21.41% | -49.80% | -9.46% | 95.36% | -43.31% | -0.90% | Upgrade |
Accounts Receivable | 69.34 | 34.13 | 38.83 | 53.15 | 28.1 | 92.78 | Upgrade |
Other Receivables | - | 0.14 | 0.92 | 0.9 | 9.27 | 10.81 | Upgrade |
Receivables | 69.43 | 34.47 | 39.96 | 54.21 | 37.49 | 103.74 | Upgrade |
Inventory | 106.23 | 104.67 | 60.17 | 47.91 | 47.24 | 2.57 | Upgrade |
Prepaid Expenses | - | 1.84 | 2.25 | 2.57 | 3.25 | 0.01 | Upgrade |
Other Current Assets | 34.64 | 32.03 | 25.05 | 24.92 | 31.64 | 16.97 | Upgrade |
Total Current Assets | 212.19 | 175 | 131.4 | 133.99 | 121.87 | 127.25 | Upgrade |
Property, Plant & Equipment | 4.23 | 4.6 | 3.33 | 3.72 | 3.86 | 1.42 | Upgrade |
Long-Term Accounts Receivable | - | 20.14 | 6.59 | 5.99 | 5.88 | 8.55 | Upgrade |
Long-Term Deferred Tax Assets | 5.15 | 5.15 | 4.57 | 1.59 | 6.24 | 1.51 | Upgrade |
Other Long-Term Assets | - | - | 0 | - | - | -0 | Upgrade |
Total Assets | 221.57 | 204.89 | 145.89 | 145.3 | 137.85 | 138.74 | Upgrade |
Accounts Payable | 180.25 | 82.38 | 56.75 | 64.69 | 40.52 | 26.59 | Upgrade |
Accrued Expenses | 0.69 | 2.8 | 3.5 | 4.69 | 4.93 | 6.2 | Upgrade |
Current Income Taxes Payable | - | 0.26 | 0.25 | 1.51 | 7.22 | 7.06 | Upgrade |
Other Current Liabilities | 3.57 | 7.83 | 4.58 | 9.58 | 10.55 | 9.18 | Upgrade |
Total Current Liabilities | 184.52 | 93.27 | 65.08 | 80.47 | 63.21 | 49.03 | Upgrade |
Pension & Post-Retirement Benefits | - | 0.8 | 1.03 | 0.83 | 0.64 | 1.18 | Upgrade |
Other Long-Term Liabilities | - | 77.2 | 29.13 | 0.91 | 1.79 | 0.58 | Upgrade |
Total Liabilities | 184.52 | 171.27 | 95.24 | 82.21 | 65.64 | 50.79 | Upgrade |
Common Stock | 30 | 30 | 30 | 30 | 30 | 30 | Upgrade |
Additional Paid-In Capital | - | 15.2 | 15.2 | 15.2 | 15.2 | 15.2 | Upgrade |
Retained Earnings | - | -11.73 | 5.3 | 17.74 | 26.85 | 42.6 | Upgrade |
Comprehensive Income & Other | 7.05 | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | Upgrade |
Shareholders' Equity | 37.05 | 33.62 | 50.65 | 63.09 | 72.2 | 87.95 | Upgrade |
Total Liabilities & Equity | 221.57 | 204.89 | 145.89 | 145.3 | 137.85 | 138.74 | Upgrade |
Net Cash (Debt) | 1.89 | 1.99 | 3.97 | 4.39 | 2.25 | 3.96 | Upgrade |
Net Cash Growth | -21.41% | -49.80% | -9.46% | 95.36% | -43.31% | -0.90% | Upgrade |
Net Cash Per Share | 0.68 | 0.66 | 1.32 | 1.46 | 0.75 | 1.32 | Upgrade |
Filing Date Shares Outstanding | 2.86 | 3 | 3 | 3 | 3 | 3 | Upgrade |
Total Common Shares Outstanding | 2.86 | 3 | 3 | 3 | 3 | 3 | Upgrade |
Working Capital | 27.67 | 81.74 | 66.32 | 53.53 | 58.66 | 78.23 | Upgrade |
Book Value Per Share | 12.97 | 11.21 | 16.88 | 21.03 | 24.07 | 29.31 | Upgrade |
Tangible Book Value | 37.05 | 33.62 | 50.65 | 63.09 | 72.2 | 87.95 | Upgrade |
Tangible Book Value Per Share | 12.97 | 11.21 | 16.88 | 21.03 | 24.07 | 29.31 | Upgrade |
Machinery | - | 10.24 | 7.83 | 7.71 | 6.75 | 3.78 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.